Monica Niger

18PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyGene and molecular therapyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 30, 2025
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study.

Chiara Pircher, Federico Nichetti, Mario Domenico Rizzato

|Nov 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda

|Aug 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.

Monica Niger, Margherita Rimini, Florian Castet

|Jul 11, 2025
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.

Federica Lo Prinzi, Francesca Salani, Silvia Camera

|Jun 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Federico Nichetti, Marta Brambilla, Matteo Duca

|May 19, 2025
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study.

Margherita Rimini, Lorenzo Fornaro, Federica Lo Prinzi

Pageof 3

Frequent Collaborators

7 joint publications

Federico Nichetti

6 joint publications

Filippo Pietrantonio

4 joint publications

Margherita Rimini

3 joint publications

Elena Conca